The corridor task:: Striatal lesion effects and graft-mediated recovery in a model of Huntington's disease

被引：13
|
作者：
Dobrossy, Mate D. [1 ]
Dunnett, Stephen B. [1 ]
机构：
[1] Univ Cardiff Wales, Brain Repair Grp, Sch Biosci, Cardiff CF10 3US, Wales
来源：
BEHAVIOURAL BRAIN RESEARCH | 2007年 / 179卷 / 02期
基金：
英国医学研究理事会;
关键词：
corridor task; striatal lesions; embryonic grafts; Huntington's disease; neurotransplantation;
D O I：
10.1016/j.bbr.2007.02.030
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
Experimental validation of cell replacement therapy as a treatment of neurodegenerative diseases requires the demonstration of graft-mediated behavioural recovery. The Corridor task proved to be simple and efficient to conduct with a robust ipsilateral retrieval bias in our rodent Huntington's disease model. The Corridor task is a viable behavioural option, particularly to non-specialised laboratories, for the evaluation of lateralised striatal damage and the probing of alternative therapeutic strategies, including transplantation. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码：326 / 330
页数：5
相关论文
共 50 条
  • [41] Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease
    Gubert, Carolina
    Kong, Geraldine
    Costello, Callum
    Adams, Cameron D.
    Masson, Bethany A.
    Qin, Wendy
    Choo, Jocelyn
    Narayana, Vinod K.
    Rogers, Geraint
    Renoir, Thibault
    Furness, John B.
    Hannan, Anthony J.
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 116 : 404 - 418
  • [42] Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease
    Ryu, JK
    Kim, SU
    McLarnon, JG
    EXPERIMENTAL NEUROLOGY, 2003, 183 (02) : 700 - 704
  • [43] Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model
    Choo, YS
    Mao, ZK
    Johnson, GVW
    Lesort, M
    NEUROSCIENCE LETTERS, 2005, 386 (01) : 63 - 68
  • [44] Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease
    Blum, D
    Galas, MC
    Gall, D
    Cuvelier, L
    Schiffmann, SN
    NEUROBIOLOGY OF DISEASE, 2002, 10 (03) : 410 - 426
  • [45] Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease
    Traficante, Anna
    Riozzi, Barbara
    Cannella, Milena
    Rampello, Liborio
    Squitieri, Ferdinando
    Battaglia, Giuseppe
    NEUROREPORT, 2007, 18 (18) : 1997 - 2000
  • [46] Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease
    Lee, Soon-Tae
    Chu, Kon
    Park, Jung-Eun
    Kang, Lami
    Ko, Song-Yi
    Jung, Keun-Hwa
    Kim, Manho
    BRAIN RESEARCH, 2006, 1118 : 199 - 207
  • [47] Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease
    Borlongan, CV
    Koutouzis, TK
    Poulos, SG
    Saporta, S
    Sanberg, PR
    CELL TRANSPLANTATION, 1998, 7 (02) : 131 - 135
  • [48] Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease
    Dorner, Jenelle L.
    Miller, Benjamin R.
    Barton, Scott J.
    Brock, Tyler J.
    Rebec, George V.
    BEHAVIOURAL BRAIN RESEARCH, 2007, 178 (01) : 90 - 97
  • [49] Adenosine A2A antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease
    Gianfriddo, M
    Corsi, C
    Melani, A
    Pèzzola, A
    Reggio, R
    Popoli, P
    Pedata, F
    BRAIN RESEARCH, 2003, 979 (1-2) : 225 - 229
  • [50] Deep brain stimulation and stereotactic-assisted brain graft injection targeting fronto-striatal circuits for Huntington's disease: an update
    Kinfe, Thomas
    Del Vecchio, Alessandro
    Nussel, Martin
    Zhao, Yining
    Stadlbauer, Andreas
    Buchfelder, Michael
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2022, 22 (09) : 781 - 788
12345